1. Home
  2. IQV vs DRI Comparison

IQV vs DRI Comparison

Compare IQV & DRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IQV
  • DRI
  • Stock Information
  • Founded
  • IQV 1982
  • DRI 1968
  • Country
  • IQV United States
  • DRI United States
  • Employees
  • IQV N/A
  • DRI N/A
  • Industry
  • IQV Biotechnology: Commercial Physical & Biological Resarch
  • DRI Restaurants
  • Sector
  • IQV Health Care
  • DRI Consumer Discretionary
  • Exchange
  • IQV Nasdaq
  • DRI Nasdaq
  • Market Cap
  • IQV 25.6B
  • DRI 25.5B
  • IPO Year
  • IQV 2013
  • DRI 1995
  • Fundamental
  • Price
  • IQV $154.78
  • DRI $225.44
  • Analyst Decision
  • IQV Buy
  • DRI Buy
  • Analyst Count
  • IQV 20
  • DRI 25
  • Target Price
  • IQV $226.80
  • DRI $214.48
  • AVG Volume (30 Days)
  • IQV 2.3M
  • DRI 1.4M
  • Earning Date
  • IQV 07-21-2025
  • DRI 06-20-2025
  • Dividend Yield
  • IQV N/A
  • DRI 2.48%
  • EPS Growth
  • IQV 0.26
  • DRI 4.26
  • EPS
  • IQV 7.35
  • DRI 8.87
  • Revenue
  • IQV $15,497,000,000.00
  • DRI $12,076,700,000.00
  • Revenue This Year
  • IQV $5.37
  • DRI $9.81
  • Revenue Next Year
  • IQV $5.19
  • DRI $3.65
  • P/E Ratio
  • IQV $21.12
  • DRI $25.48
  • Revenue Growth
  • IQV 2.84
  • DRI 6.03
  • 52 Week Low
  • IQV $134.65
  • DRI $135.87
  • 52 Week High
  • IQV $252.88
  • DRI $228.27
  • Technical
  • Relative Strength Index (RSI)
  • IQV 55.12
  • DRI 68.97
  • Support Level
  • IQV $153.23
  • DRI $215.52
  • Resistance Level
  • IQV $159.85
  • DRI $226.98
  • Average True Range (ATR)
  • IQV 4.39
  • DRI 4.21
  • MACD
  • IQV 0.96
  • DRI 0.46
  • Stochastic Oscillator
  • IQV 67.09
  • DRI 82.02

About IQV IQVIA Holdings Inc.

Iqvia is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The research and development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The technology and analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.

About DRI Darden Restaurants Inc.

Darden Restaurants is the largest restaurant operator in the US full-service space, with consolidated revenue of $11.4 billion in fiscal 2024 resulting in 3%-4% full-service market share (per NRA data and our calculations). The company maintains a portfolio of 11 restaurant brands: Olive Garden, LongHorn Steakhouse, Cheddar's Scratch Kitchen, Ruth's Chris, Yard House, The Capital Grille, Seasons 52, Eddie V's, Bahama Breeze, The Capital Burger, and most recently, Chuy's. Darden generates revenue almost exclusively from company-owned restaurants, though a small network of franchised restaurants and consumer-packaged goods sales through the traditional grocery channel contribute modestly. As of the end of its fiscal 2024, the company operated 2,031 restaurants in the US.

Share on Social Networks: